Red Cat Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Red Cat Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Apr 30, 2024 | $17.84M | Aug 8, 2024 |
| FY2024 | Apr 30, 2023 | $4.62M | Aug 8, 2024 |
| FY2023 | Apr 30, 2022 | $6.43M | Jul 27, 2023 |
| FY2022 | Apr 30, 2021 | $5.00M | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | $403.9K | Aug 12, 2021 |
| FY2018 | Dec 31, 2018 | $105.1K | Apr 1, 2019 |
| FY2017 | Dec 31, 2017 | $933 | Apr 9, 2018 |
| FY2017 | Dec 31, 2016 | $203.6K | Apr 9, 2018 |
| FY2015 | Dec 31, 2015 | $59.4K | Apr 13, 2016 |
| FY2015 | Dec 31, 2014 | $42.1K | Apr 13, 2016 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $40.73M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $4.85M | Mar 19, 2026 |
| FY2025 | Apr 30, 2024 | $17.84M | Mar 19, 2026 |
| FY2024 | Apr 30, 2023 | $1.31M | Aug 8, 2024 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.27M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | ($1.36M) | Mar 19, 2026 |
| FY2025 | Apr 30, 2024 | $3.68M | Mar 19, 2026 |
| FY2024 | Apr 30, 2023 | ($834.3K) | Aug 8, 2024 |
| FY2023 | Apr 30, 2022 | $925.5K | Jul 27, 2023 |
| FY2022 | Apr 30, 2021 | $1.07M | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | $78.6K | Aug 12, 2021 |
| FY2018 | Dec 31, 2018 | ($246.7K) | Apr 1, 2019 |
| FY2017 | Dec 31, 2017 | $653 | Apr 9, 2018 |
| FY2017 | Dec 31, 2016 | $203.6K | Apr 9, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($72.08M) | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | ($43.61M) | Mar 19, 2026 |
| FY2025 | Apr 30, 2024 | ($24.05M) | Mar 19, 2026 |
| FY2024 | Apr 30, 2023 | ($28.11M) | Aug 8, 2024 |
| FY2023 | Apr 30, 2022 | ($11.69M) | Jul 27, 2023 |
| FY2022 | Apr 30, 2021 | ($13.24M) | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | ($1.60M) | Aug 12, 2021 |
| FY2020 | Apr 30, 2019 | ($751.3K) | Aug 13, 2020 |
| FY2018 | Dec 31, 2018 | ($2.64M) | Apr 1, 2019 |
| FY2018 | Dec 31, 2017 | $1.13M | Apr 1, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($66.60M) | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | ($25.84M) | Mar 19, 2026 |
| FY2025 | Apr 30, 2024 | ($19.30M) | Mar 19, 2026 |
| FY2024 | Apr 30, 2023 | ($26.38M) | Aug 8, 2024 |
| FY2020 | Apr 30, 2020 | ($1.66M) | Aug 13, 2020 |
| FY2020 | Apr 30, 2019 | ($751.3K) | Aug 13, 2020 |
| FY2018 | Dec 31, 2018 | ($2.08M) | Apr 1, 2019 |
| FY2018 | Dec 31, 2017 | ($1.09M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($1.45M) | Apr 9, 2018 |
| FY2015 | Dec 31, 2015 | ($239.0K) | Apr 13, 2016 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.89M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $6.61M | Mar 19, 2026 |
| FY2025 | Apr 30, 2024 | $6.27M | Mar 19, 2026 |
| FY2024 | Apr 30, 2023 | $5.60M | Aug 8, 2024 |
| FY2023 | Apr 30, 2022 | $2.61M | Jul 27, 2023 |
| FY2022 | Apr 30, 2021 | $516.1K | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | $489.0K | Aug 12, 2021 |
| FY2020 | Apr 30, 2019 | $366.6K | Aug 13, 2020 |
| FY2017 | Dec 31, 2017 | $993.9K | Apr 9, 2018 |
| FY2017 | Dec 31, 2016 | $860.5K | Apr 9, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $230.4K | Mar 28, 2013 |
| FY2012 | Dec 31, 2011 | $53.8K | Mar 28, 2013 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Apr 30, 2023 | ($29.20M) | Jul 27, 2023 |
| FY2023 | Apr 30, 2022 | ($16.02M) | Jul 27, 2023 |
| FY2022 | Apr 30, 2021 | ($1.40M) | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | ($811.6K) | Aug 12, 2021 |
| FY2020 | Apr 30, 2019 | ($753.4K) | Aug 13, 2020 |
| FY2018 | Dec 31, 2018 | ($943.6K) | Apr 1, 2019 |
| FY2018 | Dec 31, 2017 | ($1.44M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($1.59M) | Apr 9, 2018 |
| FY2015 | Dec 31, 2015 | ($112.5K) | Apr 13, 2016 |
| FY2015 | Dec 31, 2014 | ($216.7K) | Apr 13, 2016 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $0 | Apr 13, 2016 |
| FY2015 | Dec 31, 2014 | $0 | Apr 13, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $273.68M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $55.60M | Mar 19, 2026 |
| FY2024 | Apr 30, 2024 | $48.54M | Aug 8, 2024 |
| FY2024 | Apr 30, 2023 | $60.74M | Aug 8, 2024 |
| FY2023 | Apr 30, 2022 | $85.08M | Jul 27, 2023 |
| FY2022 | Apr 30, 2021 | $11.69M | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | $2.81M | Aug 12, 2021 |
| FY2020 | Apr 30, 2019 | $603.4K | Aug 13, 2020 |
| FY2018 | Dec 31, 2018 | $262.4K | Apr 1, 2019 |
| FY2018 | Dec 31, 2017 | $750.2K | Apr 1, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.85M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $5.49M | Mar 19, 2026 |
| FY2018 | Dec 31, 2018 | $2.77M | Apr 1, 2019 |
| FY2018 | Dec 31, 2017 | $2.61M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $4.43M | Apr 9, 2018 |
| FY2015 | Dec 31, 2015 | $312.7K | Apr 13, 2016 |
| FY2015 | Dec 31, 2014 | $308.6K | Apr 13, 2016 |
| FY2014 | Dec 31, 2013 | $27.7K | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | $98.7K | Mar 17, 2014 |
| FY2012 | Dec 31, 2011 | $1.08M | Mar 28, 2013 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $245.83M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $50.12M | Mar 19, 2026 |
| FY2025 | Apr 30, 2024 | $43.56M | Mar 19, 2026 |
| FY2025 | Apr 30, 2023 | $54.77M | Mar 19, 2026 |
| FY2024 | Apr 30, 2022 | $79.09M | Aug 8, 2024 |
| FY2023 | Apr 30, 2021 | $5.27M | Jul 27, 2023 |
| FY2022 | Apr 30, 2020 | $1.53M | Aug 15, 2022 |
| FY2021 | Apr 30, 2019 | ($187.3K) | Aug 12, 2021 |
| FY2018 | Dec 31, 2018 | ($2.51M) | Apr 1, 2019 |
| FY2020 | Apr 30, 2018 | $514.1K | Aug 13, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.67M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $17.67M | Mar 19, 2026 |
| FY2024 | Apr 30, 2024 | $9.09M | Aug 8, 2024 |
| FY2024 | Apr 30, 2023 | $17.01M | Aug 8, 2024 |
| FY2023 | Apr 30, 2022 | $25.14M | Jul 27, 2023 |
| FY2022 | Apr 30, 2021 | $8.02M | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | $2.47M | Aug 12, 2021 |
| FY2015 | Dec 31, 2015 | $0 | Apr 13, 2016 |
| FY2015 | Dec 31, 2014 | $256.0K | Apr 13, 2016 |
| FY2014 | Dec 31, 2013 | $0 | Mar 31, 2015 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($196.82M) | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | ($124.75M) | Mar 19, 2026 |
| FY2024 | Apr 30, 2024 | ($81.13M) | Aug 8, 2024 |
| FY2024 | Apr 30, 2023 | ($57.08M) | Aug 8, 2024 |
| FY2023 | Apr 30, 2022 | ($27.50M) | Jul 27, 2023 |
| FY2022 | Apr 30, 2021 | ($15.81M) | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | ($2.57M) | Aug 12, 2021 |
| FY2020 | Apr 30, 2019 | ($971.8K) | Aug 13, 2020 |
| FY2018 | Dec 31, 2018 | ($5.38M) | Apr 1, 2019 |
| FY2018 | Dec 31, 2017 | ($2.74M) | Apr 1, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $5.8K | Apr 1, 2019 |
| FY2018 | Dec 31, 2017 | $559.2K | Apr 1, 2019 |
| FY2018 | Dec 31, 2016 | $225.4K | Apr 1, 2019 |
| FY2017 | Dec 31, 2015 | $3.2K | Apr 9, 2018 |
| FY2013 | Dec 31, 2013 | $7.0K | Mar 17, 2014 |
| FY2013 | Dec 31, 2012 | $94.6K | Mar 17, 2014 |
| FY2013 | Dec 31, 2011 | $12.0K | Mar 17, 2014 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $0 | Mar 17, 2014 |
| FY2013 | Dec 31, 2012 | $0 | Mar 17, 2014 |
| FY2012 | Dec 31, 2011 | $0 | Mar 28, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 19, 2026 |
| FY2025 | Apr 30, 2024 | 0 | Mar 19, 2026 |
| FY2018 | Dec 31, 2018 | 0 | Apr 1, 2019 |
| FY2018 | Dec 31, 2017 | 0 | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 9, 2018 |
| FY2015 | Dec 31, 2015 | 0 | Apr 13, 2016 |
| FY2015 | Dec 31, 2014 | (6) | Apr 13, 2016 |
| FY2014 | Dec 31, 2013 | 0 | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | 0 | Mar 17, 2014 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 19, 2026 |
| FY2025 | Apr 30, 2024 | 0 | Mar 19, 2026 |
| FY2018 | Dec 31, 2018 | 0 | Apr 1, 2019 |
| FY2018 | Dec 31, 2017 | 0 | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 9, 2018 |
| FY2015 | Dec 31, 2015 | 0 | Apr 13, 2016 |
| FY2015 | Dec 31, 2014 | (2) | Apr 13, 2016 |
| FY2014 | Dec 31, 2013 | 0 | Mar 31, 2015 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 120.07M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | 85.22M | Mar 19, 2026 |
| FY2025 | Apr 30, 2024 | 74.29M | Mar 19, 2026 |
| FY2024 | Apr 30, 2023 | 54.57M | Aug 8, 2024 |
| FY2023 | Apr 30, 2022 | 53.75M | Jul 27, 2023 |
| FY2022 | Apr 30, 2021 | 29.43M | Aug 15, 2022 |
| FY2021 | Apr 30, 2020 | 20.01M | Aug 12, 2021 |
| FY2020 | Apr 30, 2019 | 179,292 | Aug 13, 2020 |
| FY2018 | Dec 31, 2018 | 235.46M | Apr 1, 2019 |
| FY2018 | Dec 31, 2017 | 47.27M | Apr 1, 2019 |